Association of uridine diphosphate-glucuronosyltransferase 2B gene variants with serum glucuronide levels and prostate cancer risk

Genetic Testing and Molecular Biomarkers

Volumn 17, Issue 1, 2013, Pages 3-9

  Grant, Delores J ^a   Hoyo, Cathrine ^b   Oliver, Shannon D ^a   Gerber, Leah ^b   Shuler, Katie ^b   Calloway, Elizabeth ^b   Gaines, Alexis R ^b   McPhail, Megan ^b   Livingston, Jonathan N ^a   Richardson, Ricardo M ^a   Schildkraut, Joellen M ^c   Freedland, Stephen J ^b,d,e  

^a NORTH CAROLINA CENTRAL UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c Cancer Prevention   (United States)

^d DURHAM VA MEDICAL CENTER   (United States)

^e DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANEDIOL; GENOMIC DNA; GLUCURONOSYLTRANSFERASE; GLUCURONOSYLTRANSFERASE 2B15; GLUCURONOSYLTRANSFERASE 2B17; GLUCURONOSYLTRANSFERASE 2B7; UNCLASSIFIED DRUG;

ADULT; AGE; ALLELE; ARTICLE; CANCER RISK; CONTROLLED STUDY; ENZYME BLOOD LEVEL; ETHNICITY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; SERODIAGNOSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ALLELES; CASE-CONTROL STUDIES; GENETIC VARIATION; GENOTYPE; GLUCURONIDES; GLUCURONOSYLTRANSFERASE; HOMOZYGOTE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS;

EID: 84871226848     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2012.0161     Document Type: Article

References (31)

1. Antonelli JA, Jones LW, Banez LL, et al. (2009) Exercise and prostate cancer risk in a cohort of veterans undergoing prostate needle biopsy. J Urol 182:2226-2231.
2. Chouinard S, Barbier O, Belanger A (2007) UDP-glucuronosyltransferase 2B15 (UGT2B15) and UGT2B17 enzymes are major determinants of the androgen response in prostate cancer LNCaP cells. J Biol Chem 282:33466-33474. (Pubitemid 350159554)
3. Chouinard S, Yueh MF, Tukey RH, et al. (2008) Inactivation by UDP-glucuronosyltransferase enzymes: the end of androgen signaling. J Steroid Biochem Mol Biol 109:247-253.
4. Cunningham JM, Hebbring SJ, McDonnell SK, et al. (2007) Evaluation of genetic variations in the androgen and estrogenmetabolic pathways as risk factors for sporadic and familial prostate cancer. Cancer Epidemiol Biomarkers Prev 16:969- 978. (Pubitemid 46910099)
5. Gallagher CJ, Kadlubar FF, Muscat JE, et al. (2007) The UGT2B17 gene deletion polymorphism and risk of prostate cancer A Case-control Study In Caucasians. Cancer Detect Prev 31:310- 315 (Pubitemid 47562635)
6. Gsur A, Preyer M, Haidinger G, et al. (2002) A polymorphism in the UDP-glucuronosyltransferase 2B15 gene (D85Y) is not associated with prostate cancer risk. Cancer Epidemiol Biomarkers Prev 11:497-498. (Pubitemid 34517947)
7. Hajdinjak T, Zagradisnik B (2004) Prostate cancer and polymorphism D85Y in gene for dihydrotestosterone degrading enzyme UGT2B15: frequency of DD homozygotes increases with Gleason Score. Prostate 59:436-439. (Pubitemid 38661811)
8. Hsing AW (2001) Hormones and prostate cancer: what's next? Epidemiol Rev 23:42-58. (Pubitemid 32906613)
9. Hu DG, Gardner-Stephen D, Severi G, et al. (2010) A novel polymorphism in a forkhead box A1 (FOXA1) binding site of the human UDP glucuronosyltransferase 2B17 gene modulates promoter activity and is associated with altered levels of circulating androstane-3alpha,17beta-diol glucuronide. Mol Pharmacol 78:714-722.
10. Izukawa T, Nakajima M, Fujiwara R, et al. (2009) Quantitative analysis of UDP-glucuronosyltransferase (UGT) 1A and UGT2B expression levels in human livers. Drug metabolismand disposition: the biological fate of chemicals 37:1759-1768.
11. Jakobsson J, Ekstrom L, Inotsume N, et al. (2006) Large differences in testosterone excretion in Korean and Swedish men are strongly associated with a UDP-glucuronosyl transferase 2B17 polymorphism. J Clin Endocrinol Metab 91:687-693. (Pubitemid 43236944)
12. Karypidis AH, Olsson M, Andersson SO, et al. (2007) Deletion polymorphism of the UGT2B17 gene is associated with increased risk for prostate cancer and correlated to gene expression in the prostate. Pharmacogenomics J 8:147-151.
13. Levesque E, Beaulieu M, Green MD, et al. (1997) Isolation and characterization of UGT2B15(Y85): a UDP-lucuronosyltransferase encoded by a polymorphic gene. Pharmacogenetics 7:317-325. (Pubitemid 27356932)
14. MacLeod SL, Nowell S, Plaxco J, et al. (2000) An allele-specific polymerase chain reaction method for the determination of the D85Y polymorphism in the human UDP-glucuronosyltransferase 2B15 gene in a case-control study of prostate cancer. Ann Surg Oncol 7:777-782.
15. Menard V, Eap O, Harvey M, et al. (2009) Copy-number variations (CNVs) of the human sex steroid metabolizing genes UGT2B17 and UGT2B28 and their associations with a UGT2B15 functional polymorphism. Human Mutat 30:1310- 1319.
16. Menard V, Eap O, Roberge J, et al. (2011) Transcriptional diversity at the UGT2B7 locus is dictated by extensive pre-mRNA splicing mechanisms that give rise to multiple mRNA splice variants. Pharmacogenet Genomics 21:631-641.
17. Nadeau G, Bellemare J, Audet-Walsh E, et al. (2011) Deletions of the androgen-metabolizing UGT2B genes have an effect on circulating steroid levels and biochemical recurrence after radical prostatectomy in localized prostate cancer. J Clin Endocrinol Metab 96:E1550-1557.
18. Olsson M, Ekstrom L, Guillemette C, et al. (2011) Correlation between circulatory, local prostatic, and intra-prostatic androgen levels. Prostate 71:909-914.
19. Olsson M, Lindstrom S, Haggkvist B, et al. (2008) The UGT2B17 gene deletion is not associated with prostate cancer risk. Prostate 68:571-575. (Pubitemid 351500217)
20. Paquet S, Fazli L, Grosse L, et al. (2011) Differential expression of the androgen-conjugating UGT2B15 and UGT2B17 enzymes in prostate tumor cells during cancer progression. J Clin Endocrin Metab 97:E428-E432.
21. Park J, Chen L, Ratnashinge L, et al. (2006) Deletion polymorphism of UDP-glucuronosyltransferase 2B17 and risk of prostate cancer in African American and Caucasian men. Cancer Epidemiol Biomarkers Prev 15:1473-1478. (Pubitemid 44299318)
22. Park J, Chen L, Shade K, et al. (2004) Asp85tyr polymorphism in the udp-glucuronosyltransferase (UGT) 2B15 gene and the risk of prostate cancer. J Urol 171:2484-2488. (Pubitemid 38625520)
23. Park JY, Tanner JP, Sellers TA, et al. (2007) Association between polymorphisms in HSD3B1 and UGT2B17 and prostate cancer risk. Urology 70:374-379. (Pubitemid 47362236)
24. Rohrmann S, Nelson WG, Rifai N, et al. (2007) Serum sex steroid hormones and lower urinary tract symptoms in Third National Health and Nutrition Examination Survey (NHANES III). Urology 69:708-713. (Pubitemid 46574931)
25. Setlur SR, Chen CX, Hossain RR, et al. (2010) Genetic variation of genes involved in dihydrotestosterone metabolism and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 19:229-239.
26. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62:10-29.
27. Swanson C, Mellstrom D, Lorentzon M, et al. (2007) The uridine diphosphate glucuronosyltransferase 2B15 D85Y and 2B17deletion polymorphisms predict the glucuronidation pattern of androgens and fat mass in men. J Clin Endocrinol Metab 92:4878-4882. (Pubitemid 350223472)
28. Turgeon D, Carrier JS, Levesque E, et al. (2001) Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members. Endocrinology 142:778-787. (Pubitemid 32222427)
29. U.S. Cancer Statistics Working Group (2010) United States Cancer Statistics: 1999-2007 Incidence and Mortality Web-based Report. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, Atlanta.
30. Valentini A, Biancolella M, Amati F, et al. (2007) Valproic acid induces neuroendocrine differentiation and UGT2B7 upregulation in human prostate carcinoma cell line. Drug metabolism and disposition: the biological fate of chemicals 35:968-972. (Pubitemid 46798607)
31. Wilson W, 3rd, Pardo-Manuel de Villena F, Lyn-Cook BD, et al. (2004) Characterization of a common deletion polymorphism of the UGT2B17 gene linked to UGT2B15. Genomics 84:707- 714. (Pubitemid 39310948)